Search the Newsreel

Upstream Earnings: ConocoPhillips’ Impact on ETF Market

ConocoPhillips reported strong second-quarter earnings, beating consensus estimates, driven by elevated oil prices. This performance is significant for the energy ETF market, as ConocoPhillips is a major holding in several key energy sector ETFs like XLE, IEO, and OILT, as well as dividend-focused ETFs …

SunocoCorp LLC 2026: Revenue $14.26B, EPS $0.76— 10-Q Summary

SunocoCorp LLC reported strong financial results for the 2026 quarter, with revenue reaching $14.26 billion and diluted EPS at $0.76. This growth was largely attributed to significant acquisitions, including Parkland, TanQuid, and Delta, which expanded their fuel terminals and distribution network. The company also …

Sunoco LP 2026: Revenue $14.26B, EPS $0.94— 10-Q Summary

Sunoco LP reported significant year-over-year growth in revenue and earnings for the quarter ended 2026, with revenue reaching $14.26 billion and diluted EPS at $0.94. This surge was primarily fueled by strategic acquisitions, including Parkland, and increased fuel volumes across an expanded retail, distribution, …

Nocera | 10-Q: Q2 2026 Earnings Report

This article provides the Q2 2026 earnings report for Nocera, as detailed in their 10-Q filing. It contains the complete financial document for the quarter.

Transcrição de resultados: ConocoPhillips supera previsão de lucro no 2º tri de 2026 - Investing.com Brasil

Earnings Call-Transkript: ConocoPhillips übertrifft Gewinnprognose für Q2 2026

Informe de resultados de ConocoPhillips: supera las previsiones del segundo trimestre de 2026

Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ...

Immunocore Holdings PLC reported strong Q2 2026 earnings, with Kimtrak generating $223 million in net revenue in the first half of 2026, marking a 16% year-over-year growth. The company presented positive five-year overall survival data for Kimtrak in uveal melanoma and is advancing three …

Immunocore Q2 2026 slides: KIMMTRAK doubles 5-year survival rates

Immunocore Holdings reported its Q2 2026 financial results, highlighting that its therapy KIMMTRAK doubled the five-year survival rates in metastatic uveal melanoma patients. The company reported $115.9 million in revenue, an 18% year-over-year growth, and narrowed its net loss significantly. Immunocore is expanding its …

Sunoco reports surge in Q2 2026 earnings and raises full-year guidance

Sunoco LP reported a significant surge in its second-quarter 2026 earnings, with net income rising to $283 million and adjusted EBITDA reaching $982 million. This strong performance led the company to raise its full-year 2026 adjusted EBITDA guidance by $400 million, now targeting $3.5 …

ConocoPhillips mit neuem CEO: Gewinn übertrifft Prognosen deutlich

FMR LLC (IMCR) discloses 4.3M Immunocore shares under amended 13G

FMR LLC and Abigail P. Johnson have reported their beneficial ownership of Immunocore Holdings plc (IMCR) common stock via an amended Schedule 13G filing. FMR LLC beneficially owns 4,307,246 shares, representing an 8.8% stake, with sole dispositive power. Abigail P. Johnson also holds sole …

ConocoPhillips’ Ryan Lance to Retire, CFO Tapped as Successor

ConocoPhillips CEO Ryan Lance is set to retire, with the company's CFO being named as his successor. This announcement was made on August 6, 2026, following Lance's appearance at the CERAWeek conference earlier in the year. The article highlights this leadership change at the …

ConocoPhillips beats second-quarter earnings as record Permian production supports results

Oil refinery ©SatyaPrem ConocoPhillips (NYSE:COP) reported stronger-than-expected second-quarter earnings on Thursday, driven by higher realised oil prices and record production from its Permian Basin operations. Shares edged higher in pre-market trading, although the company left its full-year guidance unchanged. The steady outlook limited investor …

How To Earn $500 A Month From ConocoPhillips Stock Ahead Of Q2 Earnings

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As ConocoPhillips prepares to release second-quarter earnings on Thursday, Aug. 6, some investors may be eyeing potential gains from the company's dividends. As of now, ConocoPhillips has …

ConocoPhillips (COP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

ConocoPhillips (COP) reported $19.52 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 32.4%. EPS of $3.24 for the same period compares to $1.42 a year ago. The reported revenue represents a surprise of +11.32% over the Zacks Consensus …

ConocoPhillips Q2 2026 earnings beat estimates on higher oil prices

ConocoPhillips disclosed second-quarter net income of $3.9 billion, or $3.23 per share, on Thursday, more than twice the $2.0 billion, or $1.56 per share, the company recorded in the year-earlier period. Stripping out certain items, adjusted earnings came in at $3.24 per share. Analysts …

ConocoPhillips CEO Ryan Lance to retire, kicking off leadership changes

Ryan Lance is set to retire as President and CEO of ConocoPhillips after 14 years. Andy O'Brien, the current CFO, has been named his successor. This leadership change marks a significant transition for the company.

ConocoPhillips CEO Ryan Lance steps down after 14 years, promoting his replacement internally

ConocoPhillips CEO Ryan Lance is stepping down in September after 14 years, transitioning to an executive chairman role. Chief Financial Officer Andy O’Brien will succeed him as CEO. This announcement follows ConocoPhillips reporting a significant second-quarter profit of $3.9 billion and a market cap …

ConocoPhillips (COP) Tops Q2 Earnings and Revenue Estimates

ConocoPhillips (COP) came out with quarterly earnings of $3.24 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

ConocoPhillips Names New CEO as Profit Boosted by Climbing Oil Prices

ConocoPhillips announced higher second-quarter profits, reaching $3.9 billion, primarily due to a 36% increase in oil and gas prices. Concurrently, the company appointed its finance chief, Andy O’Brien, as the new CEO, succeeding Ryan Lance, who will retire and become executive chair. O'Brien will …

ConocoPhillips completes $1.7 bln asset sale, hits divestiture target early

ConocoPhillips has completed the sale of $1.7 billion of noncore assets in July, reaching its $5 billion divestiture target ahead of schedule. The company also announced the retirement of CEO Ryan Lance, with CFO Andy O'Brien set to take over in September. These divestments …

ConocoPhillips beats Q2 profit estimates; shares edge up in premarket trade

Investing.com -- ConocoPhillips shares edged up in premarket trading on Thursday after the oil producer reported second-quarter adjusted earnings of $3.24 per share, beating analysts' estimates of $2.85. The company left its full-year guidance unchanged, tempering the market reaction despite record Permian output and …

ConocoPhillips’s (NYSE:COP) Q2 CY2026: Strong Sales

ConocoPhillips's (NYSE:COP) Q2 CY2026: Strong Sales Oil and gas producer ConocoPhillips (NYSE:COP) announced better-than-expected revenue in Q2 CY2026, with sales up 32.4% year on year to $19.52 billion. Its GAAP profit of $3.23 per share was 6.1% above analysts' consensus estimates. Is now the …

ConocoPhillips Says CEO Lance to Retire, Replaced by CFO O’Brien

ConocoPhillips announced that CEO Ryan Lance will retire, effective September 1st, and will be replaced by CFO Andy O’Brien. Lance will transition to the role of executive chair of the board. Konnie Haynes-Welsh, VP for finance and controller, will take over as the new …

Immunocore (NASDAQ: IMCR) returns to profit as KIMMTRAK revenue climbs

Immunocore (NASDAQ: IMCR) reported a return to profit in the first half of 2026, driven by strong KIMMTRAK sales, with net revenue from therapies climbing to $222.6 million, a 16.0% increase year-over-year. The company posted a first-half net income of $12.2 million, a significant …

ConocoPhillips names Andy O'Brien as next CEO, effective Sept. 2026

ConocoPhillips has announced that Andy O'Brien will take over as President and CEO, succeeding Ryan Lance, effective September 1, 2026. Lance, who has led the company for 14 years, will transition to executive chair of the board. Konnie Haynes-Welsh will also be appointed Senior …

ConocoPhillips announces planned leadership succession: Andy O’Brien named president and CEO, Ryan Lance to assume transitional executive chair role, Konnie Haynes-Welsh appointed CFO

Ryan Lance HOUSTON, August 06, 2026--(BUSINESS WIRE)--Today ConocoPhillips (NYSE: COP) announced that Andy O'Brien, chief financial officer and executive vice president, Strategy and Commercial, will succeed Ryan Lance as president and chief executive officer. O'Brien will join the board of directors with his appointment. …

ConocoPhillips announces second-quarter 2026 results and quarterly dividend

Reported second-quarter 2026 earnings per share of $3.23 and adjusted earnings per share of $3.24. Generated cash provided by operating activities of $7.4 billion and cash from operations (CFO) of $7.2 billion. Doubled share repurchases in the second quarter, increasing total shareholder distributions to …

ConocoPhillips headlines Thursday's earnings

ConocoPhillips is scheduled to present its earnings on Thursday, leading the lineup of companies reporting before the opening bell. Other companies presenting include Cheniere Energy, D-Wave Quantum, Datadog, and Fiserv. This report provides a quick overview of the key earnings releases for the day.

Earnings Flash (IMCR) Immunocore Posts Q2 Loss $0.02 a Share, vs. FactSet Est of $0.02 Loss

Immunocore Holdings plc reported a Q2 loss of $0.02 per share, which aligns with FactSet's estimate. This financial update follows an earlier report of their Q2 revenue reaching $115.9 million, surpassing FactSet's estimate of $110.4 million. The company, a United Kingdom-based biotechnology firm, specializes …

ConocoPhillips (COP) Pelto Island Project Puts Its Valuation Story Back In Focus

ConocoPhillips (COP) is gaining attention due to its involvement in a large habitat restoration project at Pelto Island, which aligns with the company's valuation story and recent stock performance. Despite a slight recent share price dip, the stock has shown positive long-term momentum. The …

ConocoPhillips CEO Ryan Lance departs as oil producer posts best profit since 2022

NOCERA, INC. 2026: Revenue $2.14M, Net income ($1.54M), EPS ($0.99) — 10-Q Summary

Nocera, Inc. (NCRA) reported its 2026 quarterly results with revenue of $2.14 million, a net loss of $1.54 million, and a diluted loss per share of $0.99. This represents a significant decline in revenue and increased net loss compared to the prior-year quarter, primarily …

Boeing, Northrop Grumman Lab Demo Lets P-8 Crews Task Triton Drones Mid-Mission

Boeing and Northrop Grumman successfully demonstrated a new command-and-control link allowing P-8A Poseidon crews to directly task MQ-4C Triton surveillance drones during missions. This lab test, utilizing the Universal Command and Control Interface (UCI), showed the Triton autonomously planning, collecting intelligence, and sending processed …

Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh Revenue Breakdown – FWB:6YG

Immunocore Holdings Plc (FWB:6YG) generated €340.58 million in revenue last year, primarily from its Immunotherapies segment. The United States was the largest geographical contributor, accounting for €218.81 million of the company's revenue. The article highlights the company's top-performing segment and its major market.